Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer research
Cet article, élaboré avec la contribution de cinq associations professionnelles, présente des solutions pour surmonter les obstacles qui limitent la participation des professionnels de santé (Infirmières diplômées d'État à pratique avancée, assistants médicaux, pharmaciens cliniciens...) à la recherche clinique sur le cancer
Oncology Advanced Practice Providers (APPs) including Advanced Practice Registered Nurses, Physician Assistants, and Clinical Pharmacists (CPs), play a vital role in delivering high-quality, patient-centered cancer care across the United States. Despite their widespread presence in oncology practices, APPs remain underutilized in cancer clinical research, representing a missed opportunity to expand trial access and improve patient outcomes.
Clinical trials are essential to advancing oncology care, yet participation remains critically low among adult patients. Given Oncology APPs’ and CPs’ central role in cancer care delivery, their meaningful engagement in oncology clinical trial research is imperative as the standard of oncology care. This position paper, with contributions from five professional societies, presents solutions and resources to barriers limiting APPs’ and CPs’ involvement in cancer clinical research, including gaps in education, role expectations, limited protected time, restrictive policies, insufficient financial support, and under-recognition of contributions.
Integrating APPs and CPs more fully into the clinical research enterprise is essential to improving trial access, patient outcomes, closing equity gaps, and accelerating innovation in oncology care.
Journal of the National Cancer Institute , résumé, 2026